A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver

References

• Billström Å, Hietala SO, Wirell S. (1987). Effects of metrizoate and iohexol on the liver at visceral angiography. Acta Radiol 28:707–10.
   PubMed Web of Science ®Google Scholar
• Alkreathy HM, Alkhatib MH, Al Musaddi SA, et al. (2019). Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma. Clin Exp Pharmacol Physiol 46:496–505.
   PubMed Web of Science ®Google Scholar
• Anton N, Benoit JP, Saulnier P. (2008). Design and production of nanoparticles formulated from nano-emulsion templates-a review. J Control Release 128:185–99.
   PubMed Web of Science ®Google Scholar
• Archer SG, Gray BN. (1990). Comparison of portal vein chemotherapy with hepatic artery chemotherapy in the treatment of liver micrometastases. Am J Surg 159:325–9.
   PubMed Web of Science ®Google Scholar
• Balogh J, Victor D, Asham EH, et al. (2016). Hepatocellular carcinoma: a review. J Hepatocell Carcinoma 3:41–53.
   PubMed Web of Science ®Google Scholar
• Bierman HR, Byron RL, Kelley KH, et al. (1951). Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo. J Natl Cancer Inst 12:107–31.
   PubMedGoogle Scholar
• Breedis C, Young G. (1954). The blood supply of neoplasms in the liver. Am J Pathol 30:969–77.
   PubMed Web of Science ®Google Scholar
• Bretagnol F, Maggiori L, Zappa M, et al. (2011). Selective portal vein embolization and colorectal liver metastases in rat: a new experimental model for tumor growth study. J Surg Res 171:669–74.
   PubMed Web of Science ®Google Scholar
• Cancer.org. Cancer facts & figures. Available at: http://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2019.html [last accessed October 2019].
   Google Scholar
• Cay O, Kruskal J, Thomas P, et al. (1996). Targeting of Different Ethiodized oil-doxorubicin mixtures to hypovascular hepatic metastases with intraarterial and intraportal injections. J Vasc Interv Radiol 7:409–17.
   PubMed Web of Science ®Google Scholar
• Chen EM, Quijano AR, Seo Y-E, et al. (2018). Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors. Biomaterials 178:193–203.
   PubMed Web of Science ®Google Scholar
• Choi JW, Cho H-J, Park J-H, et al. (2014). Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads. PLoS One 9:e115898.
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Chaubal MV, Shorr R. (2008). Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv Drug Deliv Rev 60:757–67.
   PubMed Web of Science ®Google Scholar
• de Baère T, Denys A, Briquet R, et al. (1998). Modification of arterial and portal hemodynamics after injection of iodized oils and different emulsions of iodized oils in the hepatic artery: an experimental study. J Vasc Interv Radiol 9:305–10.
   PubMed Web of Science ®Google Scholar
• de Baere T, Dufaux J, Roche A, et al. (1995). Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study. Radiology 194:165–70.
   PubMed Web of Science ®Google Scholar
• de Baere T, Zhang X, Aubert B, et al. (1996). Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study. Radiology 201:731–5.
   PubMed Web of Science ®Google Scholar
• European Association For The Study Of The Liver; European Organisation For Research And Treatment of Cancer. (2012). EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–43.
   PubMed Web of Science ®Google Scholar
• Fiorentini G, Aliberti C, Mulazzani L, et al. (2014). Chemoembolization in colorectal liver metastases: the rebirth. Anticancer Res 34:575–84.
   PubMed Web of Science ®Google Scholar
• Fiorentini G, Aliberti C, Tilli M, et al. (2012). Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res 32:1387–95.
   PubMed Web of Science ®Google Scholar
• Gao J, Liu J, Xie F, et al. (2019). Co-delivery of docetaxel and salinomycin to target both breast cancer cells and stem cells by PLGA/TPGS nanoparticles. Int J Nanomedicine 14:9199–216.
   PubMed Web of Science ®Google Scholar
• Guichard S, Terret C, Hennebelle I, et al. (1999). CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissues. Br J Cancer 80:364–70.
   PubMed Web of Science ®Google Scholar
• He M-K, Zou R-H, Wei W, et al. (2018). Comparison of stable and unstable ethiodized oil emulsions for transarterial chemoembolization of hepatocellular carcinoma: results of a single-center double-blind prospective randomized controlled trial. J Vasc Interv Radiol 29:1068–77.e2.
   PubMed Web of Science ®Google Scholar
• Hsiang YH, Hertzberg R, Hecht S, et al. (1985). Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260:14873–8.
   PubMed Web of Science ®Google Scholar
• Idée JM, Guiu B. (2013). Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review. Crit Rev Oncol Hematol 88:530–49.
   PubMed Web of Science ®Google Scholar
• Jensen LI, Golman K, Almén T, et al. (1980). Effect of angiographic contrast media on the liver. I. Serum concentration of enzymes after coeliacography with balloon catheter in the pig. Acta Radiol Suppl 362:57–63.
   PubMedGoogle Scholar
• Kalra AV, Kim J, Klinz SG, et al. (2014). Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion. Cancer Res 74:7003–13.
   PubMed Web of Science ®Google Scholar
• Kan Z, Ivancev K, Hägerstrand I, et al. (1989). In vivo microscopy of the liver after injection of Lipiodol into the hepatic artery and portal vein in the rat. Acta Radiol 30:419–25.
   PubMed Web of Science ®Google Scholar
• Kan Z, Ivancev K, Lunderquist A, et al. (1993). In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic metastases. Radiology 187:621–6.
   PubMed Web of Science ®Google Scholar
• Kan Z, Wright K, Wallace S. (1997). Ethiodized oil emulsions in hepatic microcirculation: in vivo microscopy in animal models. Acad Radiol 4:275–82.
   PubMed Web of Science ®Google Scholar
• Kawato Y, Aonuma M, Hirota Y, et al. (1991). Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 51:4187–91.
   PubMed Web of Science ®Google Scholar
• Kemeny N. (2007). Presurgical chemotherapy in patients being considered for liver resection. Oncologist 12:825–39.
   PubMed Web of Science ®Google Scholar
• Laffer UT, Metzger U. (1995). Intraportal chemotherapy for colorectal hepatic metastases. World J Surg 19:246–51.
   PubMed Web of Science ®Google Scholar
• Lammer J, Malagari K, Vogl T, et al. (2010). Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41–52.
   PubMed Web of Science ®Google Scholar
• Leichman CG, Jacobson JR, Modiano M, et al. (1999). Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: a Southwest Oncology Group pilot trial. Cancer 86:775–81.
   PubMed Web of Science ®Google Scholar
• Liu DM, Thakor AS, Baerlocher M, et al. (2015). A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof. Future Oncol 11:1421–8.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Real MI, Montaña X, et al. (2002). Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–9.
   PubMed Web of Science ®Google Scholar
• Malagari K, Pomoni M, Kelekis A, et al. (2010). Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33:541–51.
   PubMed Web of Science ®Google Scholar
• Martin RCG, Joshi J, Robbins K, et al. (2011). Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study. Ann Surg Oncol 18:192–8.
   PubMed Web of Science ®Google Scholar
• Munoz NM, et al. (2019). Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma. Magn Reson Imaging 57:156–64.
   PubMed Web of Science ®Google Scholar
• Nastasa V, Samaras K, Pascu ML, et al. (2014). Moderately stable emulsions produced by a double syringe method. Colloids Surf A 460:321–6.
   Google Scholar
• Nishiofuku H, et al. (2019). Factors impacting technical success rate of image-guided intra-arterial therapy in rat orthotopic liver tumor model. Am J Transl Res 11:3761–70.
   PubMed Web of Science ®Google Scholar
• Park J, Chen Y-J, Lu W-P, et al. (2014). The evolution of liver-directed treatments for hepatic colorectal metastases. Oncology (Williston Park) 28:991–1003.
   PubMed Web of Science ®Google Scholar
• Pommier Y, Leo E, Zhang H, et al. (2010). DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17:421–33.
   PubMed Web of Science ®Google Scholar
• Rahbari NN, Mehrabi A, Mollberg NM, et al. (2011). Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 253:453–69.
   PubMed Web of Science ®Google Scholar
• Rao PP, Pascale F, Seck A, et al. (2012). Irinotecan loaded in eluting beads: preclinical assessment in a rabbit VX2 liver tumor model. Cardiovasc Intervent Radiol 35:1448–59.
   PubMed Web of Science ®Google Scholar
• Ridge JA, Bading JR, Gelbard AS, et al. (1987). Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer 59:1547–53.
   PubMed Web of Science ®Google Scholar
• Sai K, Kaniwa N, Ozawa S, et al. (2002). An analytical method for irinotecan (CPT-11) and its metabolites using a high-performance liquid chromatography: parallel detection with fluorescence and mass spectrometry. Biomed Chromatogr 16:209–18.
   PubMed Web of Science ®Google Scholar
• Sanz-Altamira PM, Spence LD, Huberman MS, et al. (1997). Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Dis Colon Rectum 40:770–5.
   PubMed Web of Science ®Google Scholar
• Seki J, Sonoke S, Saheki A, et al. (2004). A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting . Int J Pharm 273:75–83.
   PubMed Web of Science ®Google Scholar
• Singh Y, Meher JG, Raval K, et al. (2017). Nanoemulsion: concepts, development and applications in drug delivery. J Control Release 252:28–49.
   PubMed Web of Science ®Google Scholar
• Tellez C, Benson AB, Lyster MT, et al. (1998). Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82:1250–9.
   PubMed Web of Science ®Google Scholar
• Tiwari SB, Amiji MM. (2006). Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J Nanosci Nanotechnol 6:3215–21.
   PubMed Web of Science ®Google Scholar
• Törnquist C, Almén T, Golman K, et al. (1980). Proteinuria following nephroangiography. VII. Comparison between ionic monomeric, monoacidic dimeric and non-ionic contrast media in the dog. Acta Radiol Suppl 362:49–52.
   PubMedGoogle Scholar
• Towu E, Al-Mufti R, Winslet M. (2004). Uptake of lipiodol-cytotoxics conjugates by hepatocellular carcinoma cells. J Pediatr Surg 39:203–6; discussion 203-6.
   PubMed Web of Science ®Google Scholar
• Vargas GM, Parmar AD, Sheffield KM, et al. (2014). Impact of liver-directed therapy in colorectal cancer liver metastases. J Surg Res 191:42–50.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Gruber T, Balzer JO, et al. (2009). Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. Radiology 250:281–9.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Lahrsow M, Albrecht MH, et al. (2018). Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation. Eur J Radiol 102:138–45.
   PubMed Web of Science ®Google Scholar
• Voigt W, Behrmann C, Schlueter A, et al. (2002). A new chemoembolization protocol in refractory liver metastasis of colorectal cancer-a feasibility study. Onkologie 25:158–64.
   PubMed Web of Science ®Google Scholar
• Wagner JS, Adson MA, Van Heerden JA, et al. (1984). The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199:502–8.
   PubMed Web of Science ®Google Scholar
• White SB, Procissi D, Chen J, et al. (2016). Characterization of CC-531 as a rat model of colorectal liver metastases. PloS One 11:e0155334.
   PubMed Web of Science ®Google Scholar
• Williams FM, Mutch E, Blain PG. (1991). Esterase activity in rat hepatocytes. Biochem Pharmacol 41:527–31.
   PubMed Web of Science ®Google Scholar
• Yan TD, Padang R, Morris DL. (2006). Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases. J Am Coll Surg 202:100–11.
   PubMed Web of Science ®Google Scholar
• Yu D-S, Li Y, Huang X-E, et al. (2012). Effect of portal vein chemotherapy on liver metastasis after surgical resection of colorectal cancer. Asian Pac J Cancer Prev 13:4699–701.
   PubMedGoogle Scholar
• Zhao H, Lu H, Gong T, et al. (2013). Nanoemulsion loaded with lycobetaine-oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activity. Int J Nanomed 8:1959–73.
   PubMed Web of Science ®Google Scholar